CG Oncology (CGON) Earnings Analysis
CG Oncology (CGON) next reports earnings on 2026-08-07, consensus EPS -0.7 USD. Last quarter (2026-05-08) it missed with EPS -0.71 USD vs -0.58 USD est (-22.4%). It has beaten estimates in 1/4 recent quarters (25%). Trailing P/E -29.62.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CGON next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | -0.7 USD |
| Revenue estimate | 0.00B |
CGON earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-08 | -0.71 USD | -0.58 USD | -22.4% | Miss |
| 2026-02-27 | -0.51 USD | -0.61 USD | +16.4% | Beat |
| 2025-11-14 | -0.57 USD | -0.55902 USD | -2% | Miss |
| 2025-08-08 | -0.54 USD | -0.49 USD | -10.2% | Miss |
Beat rate: 1/4 (25%) over reported quarters with consensus data.
CGON valuation and analyst view
| Trailing P/E | -29.62 |
|---|---|
| Trailing EPS | -2.20952 USD |
| Price / book | 5.37 |
| Dividend yield | 0.00% |
| Market cap | 6.21B |
| Analyst consensus | Buy (10 buy / 0 hold / 0 sell) |
| Avg price target | 80.5 USD |
Related research pages
Frequently asked questions
When is CG Oncology (CGON)'s next earnings date?
CG Oncology is next scheduled to report on 2026-08-07, with a consensus EPS estimate of -0.7 USD and revenue estimate of 0.00B.
Did CGON beat earnings last quarter?
In its 2026-05-08 report, CGON posted EPS of -0.71 USD versus a -0.58 USD estimate — a miss of 22.4%.
What is CGON's earnings track record?
Over the last 4 reported quarters with consensus data, CGON beat estimates 1 times (25%).
What is CGON's current P/E ratio and EPS?
CGON trades at a trailing P/E of -29.62 on trailing EPS of -2.209515946045051 USD.
What do analysts rate CGON?
Analyst consensus is "Buy" across 10 ratings (0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 80.5 USD.